Lawrence Man Pleads Guilty To Conspiring To Manufacture And Distribute Counterfeit Pills
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Articles
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Emerging Drug Trends
    • Illegal Online Pharmacies
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Emerging Drug Trends
    • Illegal Online Pharmacies
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Lawrence Man Pleads Guilty To Conspiring To Manufacture And Distribute Counterfeit Pills

Lawrence Man Pleads Guilty To Conspiring To Manufacture And Distribute Counterfeit Pills

November 02, 2026
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kristen Govostes
Phone Number: (617) 557-2100

Defendant was member of a drug trafficking organization known as “La Culebra”

BOSTON – A Lawrence, Mass. man pleaded guilty in federal court in Boston to his involvement in a drug trafficking organization (DTO). Over two kilograms of suspected controlled substances and a pill press were recovered.

Jose Vasquez Lantigua, 48, pleaded guilty to one count of conspiracy to manufacture, distribute and possess with intent to distribute and manufacture controlled substances. U.S. Senior District Court Judge Patti B. Saris scheduled sentencing for Jan. 28, 2027. Lantigua was arrested and charged in August 2025 along with co-conspirator Manuel Santana-Soto.

According to the charging documents, Lantigua and the La Culebra DTO controlled a large drug manufacturing location inside an apartment in Methuen, where a controlled purchase of drugs from Joshua Morales, a drug runner associated with La Culebra, occurred. During a search of the apartment, investigators observed fresh footprints in powders believed to be controlled substances. Those footprints led down an interior staircase to a second-floor apartment, where Lantigua and Santana-Soto were encountered wearing flip flops with soles that matched the powdered footprints found.  

Shortly thereafter, the listed tenant of the second-floor apartment informed law enforcement that Lantigua and Santana-Soto did not have permission to be in her apartment and did not have a key to access to the apartment. Lantigua and Santana-Soto were believed to have fled the third-floor unit and broken into the second-floor unit before officers made entry.

During a search of the third-floor apartment, an automated pill press was located, along with multiple kilograms of counterfeit Adderall and Percocet pills believed to contain fentanyl and methamphetamine. Numerous implements used in the pill manufacturing process were also located, including cutting agents, blenders, scales, bowls and bags full of suspected fentanyl and methamphetamine powders and binding agents.

Santana-Soto pleaded guilty in May 2026 and is scheduled to be sentenced on Dec. 8, 2026. Morales pleaded guilty in March 2026 and is scheduled to be sentenced on Nov. 10, 2026. Aris Arvelo Gonzalez, another member of La Culebra, was charged in November 2025 following a series of controlled purchases and identification of another manufacturing location. Gonzalez pleaded guilty in September 2026 and is scheduled to be sentenced on Jan. 13, 2027.

The charge of conspiracy to manufacture, distribute and possess with intent to distribute or manufacture a controlled substance provides for sentence of at least 10 years and up to life  in prison, at least five years and up to a lifetime of supervised release and a fine of up to $10 million. The charge of manufacturing and possessing a controlled substance with intent to distribute or manufacture provides for a sentence of at least 10 years and up to life in prison, at least five years and up to a lifetime of supervised release and a fine of up to $10 million. Sentences are imposed by a federal district court judge based upon the U.S. Sentencing Guidelines and statutes which govern the determination of a sentence in a criminal case.

United States Attorney Leah B. Foley; Ted E. Docks, Special Agent in Charge of the Federal Bureau of Investigation, Boston Division; Jarod A. Forget, Special Agent in Charge of the Drug Enforcement Administration in New England; and Colonel Geoffrey D. Noble, Superintendent of the Massachusetts State Police made the announcement today. Valuable assistance was provided by the Essex County District Attorney’s Office. Assistant U.S. Attorney Philip A. Mallard of the Organized Crime & Gang Unit is prosecuting the case.

Download Press Release
###
Fentanyl Methamphetamine
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Jarod Forget Special Agent in Charge - New England
@DEANewEngland
  • Facebook
  • X
  • linkedin
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster